Inpegsomatropin Injection

DRUG3 trials

Sponsors

Xiamen Amoytop Biotech Co., Ltd.

Conditions

Adult Growth Hormone DeficiencyIdiopathic Short StatureSmall for Gestational Age

Phase 2

Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency

RecruitingNCT07551804

Xiamen Amoytop Biotech Co., Ltd.Adult Growth Hormone Deficiency

Start: 2026-06-10End: 2028-06-30Target: 36Updated: 2026-07-22

Phase 3

The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature

RecruitingNCT06927310

Xiamen Amoytop Biotech Co., Ltd.Idiopathic Short Stature

Start: 2025-04-28End: 2028-06-01Target: 300Updated: 2026-03-11

The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age

RecruitingNCT07309562

Xiamen Amoytop Biotech Co., Ltd.Small for Gestational Age

Start: 2026-01-20End: 2028-05-07Target: 141Updated: 2026-05-08